Embryonal Tumor

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors [Phase 1, Phase 2]

  A Phase 1/2 clinical trial evaluating Lutathera (lutetium-177 dotatate) for recurrent or progressive high-grade central nervous system tumor…

• CLINICAL_TRIALS research · 2025-12-17
  Clinical Trial Update: Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification

  This clinical trial update describes an observational study by the EORTC to assess treatment patterns and outcomes for patients with primary…

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients [Phase 1]

  A Phase 1 safety study evaluating repeated opening of the blood-brain barrier using the SonoCloud device to treat pediatric malignant brain …

• CLINICAL_TRIALS research · 2025-09-04
  Clinical Trial Update: C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) [Phase 1]

  Phase 1 clinical trial update for C7R-GD2.CAR T cells targeting GD2-expressing brain tumors, currently recruiting for DIPG, high-grade gliom…

• CLINICAL_TRIALS research · 2025-03-25
  Clinical Trial Update: Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas

  This clinical trial update outlines an integrated analysis of how embryonal tumors and gliomas respond to therapy and develop resistance, in…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-02-05
  Clinical Trial Update: GD2-CAR T Cells for Pediatric Brain Tumours [Phase 1]

  Phase 1 trial evaluating GD2-CAR T cells for pediatric brain tumors is currently recruiting. The study targets medulloblastoma, embryonal tu…